Abstract:Own mother's colostrum is rich in cytokines and other immune agents that may stimulate oropharyngeal-associated lymphoid tissue if administered oropharyngeally to extremely low-birth-weight (ELBW) infants during the first days of life when enteral feeding is contraindicated. However, the safety and feasibility of the oropharyngeal route for the administration of colostrum have not been determined. Purpose: To determine the safety of oropharyngeal administration of own mother's colostrum to ELBW infants in first days of life. A secondary purpose was to investigate the feasibility of (1) delivering this intervention to ELBW infants in the first days of life and (2) measuring concentrations of secretory immunoglobulin A and lactoferrin in tracheal aspirate secretions and urine of these infants. Subjects: Five ELBW infants (mean birth weight and gestational age = 657 g and 25.5 weeks, respectively). Design: Quasi-experimental, 1 group, pretest-posttest design. Methods: Subjects received 0.2 mL of own mother's colostrum administered oropharyngeally every 2 hours for 48 consecutive hours, beginning at 48 hours of life. Concentrations of secretory immunoglobulin A and lactoferrin were measured in tracheal aspirates and urine of each subject at baseline, at the completion of the intervention and again 2 weeks later. Results: All infants completed the entire treatment protocol, each receiving 24 treatments. A total of 15 urine specimens were collected and 14 were sufficient in volume for analysis. A total of 15 tracheal aspirates were collected, but only 7 specimens (47%) were sufficient in volume for analysis. There was wide variation in concentrations of secretory immunoglobulin A and lactoferrin in urine and tracheal aspirates among the 5 infants; however, several results were outside the limits of assay detection. All infants began to suck on the endotracheal tube during the administration of colostrum drops. Oxygen saturation measures remained stable or increased slightly during each of the treatment sessions. There were no episodes of apnea, bradycardia, hypotension, or other adverse effects associated with the administration of colostrum. Conclusions: Oropharyngeal administration of own mother's colostrum is easy, inexpensive, and well-tolerated by even the smallest and sickest ELBW infants. Future research should continue to examine the optimal procedure for measuring the direct immune effects of this therapy, as well as the clinical outcomes such as infections, particularly ventilator-associated pneumonia.

Testing detectability, attractivity, hedonic specificity, extractability, and robustness of colostrum odor—Toward an olfactory bioassay for human neonates

Comparative Investigation of Conventional and Innovative Headspace Extraction Methods to Explore the Volatile Content of Human Milk

Odor-active volatile compounds in preterm breastmilk

Central Nervous System Processing Of Floral Odor And Mother'S Milk Odor In Infants

Olfactory stimulation in newborns: Regional differences in cerebral oxygenation

Behavioural and neurobiological effects of colostrum ingestion in the newborn lamb associated with filial bonding

Sampling, identification and sensory evaluation of odors of a newborn baby’s head and amniotic fluid

Facial Expression in Response to Smell and Taste Stimuli in Small and Appropriate for Gestational Age Newborns

Identification of Odor-Active Substances in Individual Low-Volume Amniotic Fluid Samples by a Sensorially Targeted Gas Chromatographic-Olfactometric Approach

Effects of human milk odor stimulation on feeding in premature infants: a systematic review and meta-analysis

Changes in Serum Metabolites in Response to Ingested Colostrum and Milk in Neonatal Calves, Measured by Nuclear Magnetic Resonance-Based Metabolomics Analysis.

1H NMR Metabolomics of Chinese Human Milk at Different Stages of Lactation among Secretors and Non-Secretors

Human milk oligosaccharides and the association with microbiota in colostrum: a pilot study

A pilot study to determine the safety and feasibility of oropharyngeal administration of own mother's colostrum to extremely low-birth-weight infants

Changes in the fatty acid profiles and health indexes of bovine colostrum during the first days of lactation and their impact on human health

In Love with Shaping You-Influential Factors on the Breast Milk Content of Human Milk Oligosaccharides and Their Decisive Roles for Neonatal Development

Determination of Seven Human Milk Oligosaccharides (HMOs) in Infant Formula and Adult Nutritionals: First Action 2022.07

Body odours as a chemosignal in the mother–child relationship: new insights based on an human leucocyte antigen-genotyped family cohort

Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study

Exploring the Immunomodulatory Potential of Human Milk: Aryl Hydrocarbon Receptor Activation and Its Impact on Neonatal Gut Health

An In Vitro Colonic Fermentation Study of the Effects of Human Milk Oligosaccharides on Gut Microbiota and Short-Chain Fatty Acid Production in Infants Aged 0-6 Months